Does fasting burn fat faster than eating the same calories across the day?

Not meaningfully. Trials that match calories between arms find similar fat loss. Fasting's value is that it makes the deficit easier for some people to reach without counting anything.

Does fasting wreck your metabolism?

No. Short fasting windows do not measurably damage resting metabolic rate beyond what any equivalent amount of weight loss does. Metabolic adaptation is a function of losing weight, not of when you ate.

Which protocol should I pick?

Start with 16:8 if you want the lowest-friction option, and expect a modest result. Consider 5:2 if you would rather be strict twice a week. Alternate-day fasting has the strongest comparative data and the highest dropout, which is the trade you are accepting.

Intermittent Fasting for Weight Loss: What 99 Trials Say

What this page establishes

In the BMJ network meta-analysis of 99 RCTs and 6,582 adults, alternate-day fasting was the only fasting strategy to significantly outperform continuous energy restriction, and the advantage was -1.29 kg (95% CI -1.99 to -0.59).
A systematic review and network meta-analysis comparing caloric-restriction regimens concluded the regimens are broadly comparable for weight management in adults.
In the Harvie IER trial, participants spontaneously ate about 19% less than allocated on their unrestricted days, which is a large part of why 5:2-style schedules produce a weekly deficit.

Quick answers

Does fasting burn fat faster than eating the same calories across the day?
Not meaningfully. Trials that match calories between arms find similar fat loss. Fasting's value is that it makes the deficit easier for some people to reach without counting anything.
Does fasting wreck your metabolism?
No. Short fasting windows do not measurably damage resting metabolic rate beyond what any equivalent amount of weight loss does.
Read the full answer
Metabolic adaptation is a function of losing weight, not of when you ate.
Which protocol should I pick?
Start with 16:8 if you want the lowest-friction option, and expect a modest result. Consider 5:2 if you would rather be strict twice a week.
Read the full answer
Alternate-day fasting has the strongest comparative data and the highest dropout, which is the trade you are accepting.

Fasting works. It works because it removes eating occasions, and removing eating occasions usually removes calories. It does not work because of a metabolic switch, an autophagy window, or a fat-burning state that eating disrupts. A network meta-analysis of 99 randomised trials covering 6,582 adults compared fasting protocols against continuous calorie restriction and found them broadly comparable. That is the single most useful thing to know before you pick a protocol, because it means you can choose on the basis of what fits your week.

The protocols, defined precisely

Popular usage is loose about these terms, and the trials are not. Getting the definitions straight tells you which evidence applies to what you are actually doing.

16:8 time-restricted eating: all food inside an eight-hour daily window, every day. The best-studied and least demanding protocol.
OMAD: a single meal, roughly a 23:1 window. The most aggressive common protocol and the least studied.
5:2: two days per week at heavy restriction (popularly 500-600 kcal, in trials often around 70% restriction), five days eating normally.
Alternate-day fasting: a fast or heavily restricted day every other day. The modified version allows about 500 kcal on fast days.
Extended fasting: 48 hours and beyond. A different category with real medical risk and no controlled evidence for sustained fat loss.

What the 99-trial network meta-analysis found

Across 6,582 adults, fasting protocols came out broadly comparable to continuous energy restriction. One exception reached significance: alternate-day fasting outperformed continuous restriction by a mean difference of 1.29 kg (95% CI 0.59 to 1.99). That is a real result and a small one, and it came alongside notable dropout.

A second network meta-analysis comparing caloric-restriction regimens reached the same conclusion, that the regimens are broadly comparable for weight management in adults. Reviews also report equivalence across cardiometabolic, cancer and neurocognitive outcomes, with fasting arms sometimes reporting better adherence during the trial period.

Consider what would need to be true for fasting to be metabolically special. Matched-calorie trials would show a fasting advantage. The NEJM trial that gave both arms the same calorie prescription and varied only the eating window found no advantage. The window added nothing to the deficit.

Why fasting still produces results

It compresses opportunity. Skip breakfast and you have removed a meal you would otherwise have eaten, and most people do not fully compensate at lunch. In the Harvie intermittent-energy-restriction trial, participants spontaneously ate about 19% less than allocated on their unrestricted days. Nobody asked them to. The schedule did it.

That spontaneous under-eating is the mechanism. It also explains the failure mode. When compensation does happen, when the eating window becomes a hunger-driven catch-up, the deficit disappears and the protocol stops working while the person is still following it perfectly.

The one thing to take from this page Meal timing has no metabolic magic. Every fasting protocol on this site works by producing an energy deficit, and any of them stops working the moment it stops producing one. Pick the schedule that removes food you would otherwise eat, and ignore claims about fat-burning states.

Where fasting may have a genuine edge

Adherence, for some people, and only for some. Fasting removes decisions. There is nothing to weigh and nothing to score, and for people who find tracking intolerable that is worth more than any difference in mechanism.

16:8 has the lowest dropout of the protocols here and, not coincidentally, the smallest measured effect. Alternate-day fasting has the largest measured effect and high dropout. That trade repeats across the whole cluster and it is the honest basis for choosing.

What fasting does not do

It does not raise your metabolic rate in any way that survives matched-calorie testing. It does not target visceral fat preferentially. Short fasting windows do not damage resting metabolic rate beyond what any equivalent weight loss does, so the folklore runs in both directions and both directions are wrong.

It does not protect lean mass. It tends to work against it, because a compressed window makes a 1.2-1.6 g/kg/day protein target harder to hit. That effect gets worse as the window narrows, which is why OMAD carries the highest lean-mass risk of anything in this cluster.

Who should not fast

These are not cautions to read and move past. For several of these groups, fasting protocols carry real harm potential and need a clinician's involvement before you start.

Anyone pregnant or breastfeeding.
Anyone with a current or past eating disorder. Restriction schedules are a known trigger and the risk is not hypothetical.
Anyone under 18.
Anyone with type 1 diabetes, or taking insulin or a sulfonylurea, because of hypoglycaemia risk.
Anyone on medication that must be taken with food, or that requires stable intake to dose safely.

If food and weight already feel difficult Structured restriction can escalate disordered eating quickly. If counting, skipping meals or weighing yourself is already loaded for you, this cluster is not the right starting point. In the US, the National Alliance for Eating Disorders helpline is 1-866-662-1235. In the UK, Beat runs a helpline on 0808 801 0677.

Fasting while on a GLP-1

Raise it with your prescriber before you start. GLP-1 agonists already suppress appetite heavily, and adding a fasting window stacks two appetite suppressants that operate on the same endpoint. The failure is not usually hunger, it is intake dropping low enough that protein and micronutrient targets get missed for weeks, and lean mass pays for it.

The stack builder handles this the same way: a GLP-1 selected alongside a fasting protocol does not add the two rates together, because they are routes to the same suppressed intake. It flags the combination rather than rewarding it.

The evidence, one row per claim

Claim	Tier	Source
In the BMJ network meta-analysis of 99 RCTs and 6,582 adults, alternate-day fasting was the only fasting strategy to significantly outperform continuous energy restriction, and the advantage was -1.29 kg (95% CI -1.99 to -0.59).	established	BMJ Group
A systematic review and network meta-analysis comparing caloric-restriction regimens concluded the regimens are broadly comparable for weight management in adults.	established	PMC — comparing caloric restriction regimens, network meta-analysis
Reviews report that intermittent fasting and continuous restriction were equally effective across cardiometabolic, cancer and neurocognitive outcomes, though IF studies reported greater adherence during the trial period.	emerging	Healthline summary of 2024 review (replace with the primary review before publishing)
In the Harvie IER trial, participants spontaneously ate about 19% less than allocated on their unrestricted days, which is a large part of why 5:2-style schedules produce a weekly deficit.	established	Food Sci Nutr — spontaneous energy reduction on unrestricted days

Questions people ask

Can I fast while taking a GLP-1?

Discuss it with your prescriber first. The medication already suppresses appetite hard, and adding a fasting window can push intake low enough that protein and micronutrient targets get missed, with lean mass taking the hit.

Sources

Where this comes from

Researched and edited by Thomas Prommer — biohacker, performance athlete, data enthusiast and health coach.

Every number on this page traces to a named source. There are 4 sourced claims below the fold, each with the document it came from.

Sources consulted: BMJ Group, PMC — comparing caloric restriction regimens, Healthline summary of 2024 review, Food Sci Nutr — spontaneous energy reduction on unrestricted days.

Not clinically reviewed. This page was researched and written against primary regulatory and trial sources, and no clinician has checked it.

Sources last read 2026-08-23.

Keep reading

Educational content, reviewed 2026-08-23. Not medical advice, not a prescription, and not a substitute for a clinician who knows your history. Doses named here are label schedules or doses used in named trials, never a recommendation to you.